Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Sachin Chaugule1,2,3, Christodoulos Kypros Constantinou1, Aijaz Ahmad John1,2,3
1Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Human Gene Therapy
|February 11, 2025
Summary
Osteogenesis imperfecta (OI) is a rare genetic bone disorder causing fragility. Emerging gene and stem cell therapies show promise for treating OI, offering potential long-term solutions beyond current symptomatic relief.
Area of Science:
- Genetics and Molecular Biology
- Orthopedics and Regenerative Medicine
- Rare Diseases
Background:
- Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by brittle bones, low bone mass, and recurrent fractures.
- OI exhibits significant clinical and genetic heterogeneity due to pathogenic variants in over 20 genes.
- Current treatments offer symptomatic relief but do not address the underlying causes of OI.
Purpose of the Study:
- To provide a comprehensive review of Osteogenesis Imperfecta (OI) classification and pathogenesis.
- To summarize current management strategies for OI.
- To explore emerging biotechnologies, including stem cell and gene therapies, for treating OI.
Main Methods:
- Literature review of Osteogenesis Imperfecta (OI) classification, pathogenesis, and treatment.
- Analysis of current multidisciplinary management approaches.
- Evaluation of emerging stem cell and gene-targeted therapies for OI.
Main Results:
- OI is a complex disorder with diverse genetic underpinnings and clinical manifestations.
- Existing treatments for OI are primarily palliative, focusing on symptom management.
- Gene and stem cell therapies represent promising avenues for novel OI treatments.
Conclusions:
- Innovative biotechnologies offer potential for curative or long-lasting treatments for Osteogenesis Imperfecta.
- Further research and clinical implementation are necessary to realize the full potential of these advanced therapies.
- The focus is on achieving imminent success in treating bone disorders like OI.
More Related Videos
Related Concept Videos
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
What is the Skeletal System?
52.1K
Overview
52.1K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Structure
47.9K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
47.9K


